Qing-Chun Fu

Qing-Chun Fu

Auto-generated profile, based on publicly available information

Qing-Chun Fu

Clinical Research Center for Liver Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
YQYing Qu
Ying Qu
YSYan-Yan Song
Yan-Yan Song
CCCheng-Wei Chen
Cheng-Wei Chen
QFQing-Chun Fu
Qing-Chun Fu
JSJun-ping Shi
Jun-ping Shi
LLLungen Lu
Lungen Lu
INTRODUCTION: To evaluate the diagnostic performance of ultrasound attenuation parameter (UAP) and liver stiffness measurement (LSM) by FibroTouch for diagnosis of hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). METHODS: We recruited 237 patients undergoing FibroTouch and liver biopsy within 2 weeks. The pathological findings of liver biopsy were scored by Nonalcoholic Steatohepatitis Clinical Research Network, and the diagnostic accuracy of UAP for steatosis and LSM for fibrosis was evaluated by area under the receiver operating characteristic curve (AUROC). The impacts of histological parameters on UAP and LSM were analyzed, and diagnostic performance of FibroTouch UAP and LSM was compared with other noninvasive biomarkers. RESULTS: The success rate of FibroTouch examination was 96.51%. The AUROC of UAP for diagnosis of steatosis ≥S1, ≥S2, and S3 was 0.88, 0.93, and 0.88, and the cutoff values were 244, 269, and 296 dB/m, respectively. The AUROC of LSM for the diagnosis of fibrosis stages ≥F2, ≥F3, and F4 was 0.71, 0.71, and 0.77, and the cutoff values were 9.4, 9.4, and 11 kPa, respectively. Multiple regression analysis showed that LSM was positively correlated with degree of fibrosis and NAFLD activity score. UAP was positively correlated with liver steatosis. The diagnostic performance of UAP for steatosis was significantly superior to that of the hepatic steatosis index. DISCUSSION: FibroTouch has a low failure rate with moderate to high diagnostic performance for discriminating the steatosis degree and fibrosis stage and is suitable for clinical evaluation and monitoring of patients with NAFLD.

11 January 2011 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
XLXinhua Li
Xinhua Li
YLYi Lu
Yi Lu
YLYun Ling
Yun Ling
QFQing-Chun Fu
Qing-Chun Fu
JXJie Xu
Jie Xu
XZXin-Xin Zhang
Xin-Xin Zhang
Background: Wilson's disease (WND) is a rare autosomal recessive disorder. Here we have evaluated 62 WND cases (58 probands) from the Chinese Han population to expand our knowledge of ATP7B mutations and to more completely characterize WND in China. Methods: The coding and promoter regions of the ATP7B gene were analyzed by direct sequencing in 62 Chinese patients (58 probands) with WND (male, n = 37; female, n = 25; age range, 2 ~ 61 years old). Results: Neurologic manifestations were associated with older age at diagnosis (p < 0.0001) and longer diagnostic delay (p < 0.0001). Age at diagnosis was also correlated with urinary copper concentration (r = 0.58, p < 0.001). Forty different mutations, including 14 novel mutations, were identified in these patients. Common mutations included p.Arg778Leu (31.9%) and p.Pro992Leu (11.2%). Homozygous p.Arg778Leu and nonsense mutation/frameshift mutations were more often associated with primary hepatic manifestations (p = 0.0286 and p = 0.0383, respectively) and higher alanine transaminase levels at diagnosis (p = 0.0361 and p = 0.0047, respectively). Nonsense mutation/frameshift mutations were also associated with lower serum ceruloplasmin (p = 0.0065). Conclusions: We identified 14 novel mutations and found that the spectrum of mutations of ATP7B in China is quite distinct from that of Western countries. The mutation type plays a role in predicting clinical manifestations. Genetic testing is a valuable tool to detect WND in young children, especially in patients younger than 8 years old. Four exons (8, 12, 13, and 16) and two mutations (p.Arg778Leu, p.Pro992Leu) should be considered high priority for cost-effective testing in China.

21 March 2015 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
GCGuangfeng Chen
Guangfeng Chen
YJYinpeng Jin
Yinpeng Jin
XSXiujuan Shi
Xiujuan Shi
YQYu Qiu
Yu Qiu
YZYushan Zhang
Yushan Zhang
XLXiaoqing Liu
Xiaoqing Liu
Introduction: Acute liver failure (ALF) is a highly lethal disease, for which effective therapeutic methods are limited. Although allogeneic liver transplantation is a viable treatment method for ALF, there is a serious shortage of liver donors. Recent studies suggest that stem cell transplantation is a more promising alternative. Hence, we investigate whether human adipose-derived stem cells (ASCs) have the therapeutic potential for ALF in this study based on the studies of rat models. Methods: Sprague Dawley rats were used to establish ALF models by D-galactosamine injection. These rats were randomly divided into a human ASC-treated group and a phosphate-buffered saline (PBS) control group. The human ASCs or PBS was transplanted through the spleen of rats. The indices of hepatic function and hepatic histology were dynamically detected, and the survival rates of rats were also counted. Double-fluorescence immunohistochemistry was employed to detect the ASC fate after transplantation. Moreover, both concentrated ASC conditional media and ASC lysates were transplanted through the femoral vain of rats to investigate the therapeutic potential for ALF. Results: The ASC transplantation group showed improved viability in comparison with the sham control. Histological and biochemical analysis suggested that liver morphology and function were improved in terms of cell proliferation and apoptosis. Although a plethora of ASCs persist in the spleen, the improvement in liver function was obvious. However, ASCs did not differentiate into hepatocytes after engrafting to livers within 3 days. In addition, both concentrated serum-free ASC conditional media and ASC lysates, characterized by high levels of hepatocyte growth factor and vascular endothelial growth factor, demonstrated obvious improvement in terms of high survival rates of ALF rats. Conclusion: Our data suggest that ASC transplantation has the potential for ALF treatment partly by the mechanism of secreting growth factors contributing to liver regeneration.

1 November 2009
Verified
Journal Article
Closed access
YMYi-Min Mao
Yi-Min Mao
MZMin-De Zeng
Min-De Zeng
YCYong Chen
Yong Chen
CCCheng-Wei Chen
Cheng-Wei Chen
QFQing-Chun Fu
Qing-Chun Fu
HCHong-Zhuan Chen
Hong-Zhuan Chen

1 October 2004
Verified
Journal Article
Closed access
LLLungen Lu
Lungen Lu
MZMin-De Zeng
Min-De Zeng
YMYi-Min Mao
Yi-Min Mao
MWMo-Bin Wan
Mo-Bin Wan
CLCheng-Zhong Li
Cheng-Zhong Li
WCWei-Xiong Chen
Wei-Xiong Chen

1 July 2009
Verified
Journal Article
Closed access
CCCong-Xin Chen
Cong-Xin Chen
BLBo Liu
Bo Liu
YMYong Ma
Yong Ma
YZYue-Jin Zhou
Yue-Jin Zhou
XPXing-Nan Pan
Xing-Nan Pan
CCCheng-Wei Chen
Cheng-Wei Chen